UNSPSC 51281657: Neomycin c

This classification denotes an aminoglycoside antibiotic with the molecular formula C23H46N6O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6B1U1NS16Z, chemically known as d-streptamine, o-2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranosyl-(1->3)-o-.beta.-d-ribofuranosyl-(1->5)-o-(2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranosyl-(1->4))-2-deoxy-, but more generally known as neomycin c, which bears US NIH Compound Identifier 4454.

UNSPSC 51281657 Neomycin C is a Commodity code that appears in state and local procurement activity centered on pharmaceutical procurement, though the recent opportunities posted under this code do not focus specifically on neomycin c products. Instead, the code surfaces in broader medical supply, emergency response, and generic pharmaceutical procurements where the specific active ingredient may be one of many line items or part of a larger portfolio. State and local buyers soliciting under this code include county health departments, municipal fire and rescue services, cooperative purchasing alliances serving multi-state health systems, and state health and human services agencies. Seminole County, Florida and the City of Tampa represent typical issuing bodies at the local level; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) and Texas Health and Human Services Commission show state-level and regional cooperative activity. Work being solicited ranges from emergency medical supplies for fire rescue operations to generic pharmaceutical contracting through authorized wholesalers and direct-to-manufacturer prescription programs.

Recent opportunities span Florida, Texas, and the upper Midwest. Seminole County issued IFB 60459723LAS in June 2026 to procure naloxone and drug deactivation systems for community health initiatives, with quarterly deliveries and a July 26 response deadline. The City of Tampa's Purchasing Department released IFB 26P00145 in March 2026 for medical and first aid supplies (estimated contract value $700,000) for its Fire Department Rescue Division, with a Small Local Business Enterprise set-aside and a 5 percent bid discount capped at $10,000; response deadline was March 13, 2026. MMCAP issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products across participating state and local jurisdictions, with a March 26, 2026 response deadline and an effective date of July 1, 2026. Texas HHS posted RFI HHS0017013 in April 2026 as an early-stage market inquiry into direct-to-manufacturer prescription fulfillment models, signaling preliminary interest in non-traditional pharmaceutical supply channels before formal RFP issuance.